Fingerprint
Dive into the research topics of 'A randomized phase II study of linsitinib (OSI-906) versus Topotecan in patients with relapsed small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized phase II study of linsitinib (OSI-906) versus Topotecan in patients with relapsed small-cell lung cancer
Alberto A. Chiappori, Gregory A. Otterson, Afshin Dowlati, Anne M. Traynor, Leora Horn, Taofeek K. Owonikoko, Helen J. Ross, Christine L. Hann, Taher Abu Hejleh, Jorge Nieva, Xiuhua Zhao, Michael Schell, Daniel M. Sullivan
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations